Junhai Xiao

818 total citations
61 papers, 634 citations indexed

About

Junhai Xiao is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Junhai Xiao has authored 61 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 19 papers in Oncology and 10 papers in Organic Chemistry. Recurrent topics in Junhai Xiao's work include Bacterial biofilms and quorum sensing (8 papers), Chemokine receptors and signaling (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Junhai Xiao is often cited by papers focused on Bacterial biofilms and quorum sensing (8 papers), Chemokine receptors and signaling (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Junhai Xiao collaborates with scholars based in China, Czechia and Russia. Junhai Xiao's co-authors include Song Li, Wu Zhong, Zhibing Zheng, Feng Lin, Wei Sun, Shi Hou, Lili Wang, Meihua Zhao, Hao Wu and Yongsheng Che and has published in prestigious journals such as Analytical Biochemistry, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Junhai Xiao

56 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junhai Xiao China 16 314 157 114 94 89 61 634
Midori Ishikawa Japan 11 234 0.7× 116 0.7× 110 1.0× 42 0.4× 98 1.1× 11 563
Stephen H. Prior United Kingdom 14 508 1.6× 142 0.9× 109 1.0× 42 0.4× 30 0.3× 22 809
Wenjing Chen China 17 665 2.1× 42 0.3× 103 0.9× 109 1.2× 51 0.6× 64 1.0k
Eiman Mukhtar United States 7 373 1.2× 140 0.9× 163 1.4× 32 0.3× 77 0.9× 11 759
Francesco Fiorentino Italy 19 630 2.0× 56 0.4× 190 1.7× 52 0.6× 127 1.4× 50 1.0k
Wendy T. Collard United States 14 611 1.9× 79 0.5× 166 1.5× 73 0.8× 32 0.4× 22 1.0k
Tam Dang United States 14 588 1.9× 123 0.8× 100 0.9× 176 1.9× 41 0.5× 31 956
Jiahn‐Haur Liao Taiwan 19 427 1.4× 80 0.5× 37 0.3× 61 0.6× 25 0.3× 34 643
Hongjiang Xu China 15 373 1.2× 192 1.2× 106 0.9× 36 0.4× 58 0.7× 41 773
Glenn S. Van Aller United States 10 627 2.0× 85 0.5× 116 1.0× 38 0.4× 53 0.6× 14 882

Countries citing papers authored by Junhai Xiao

Since Specialization
Citations

This map shows the geographic impact of Junhai Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhai Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhai Xiao more than expected).

Fields of papers citing papers by Junhai Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junhai Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhai Xiao. The network helps show where Junhai Xiao may publish in the future.

Co-authorship network of co-authors of Junhai Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Junhai Xiao. A scholar is included among the top collaborators of Junhai Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junhai Xiao. Junhai Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ye, Ze, et al.. (2025). Design, Synthesis, and Biological Evaluation of Indole Derivatives Targeting LsrK as AI-2 Quorum Sensing Inhibitors. Journal of Medicinal Chemistry. 68(20). 21701–21724.
3.
Zhang, Chao, Jialin Guo, Zixiao Liu, et al.. (2025). Targeting clathrin-mediated endocytosis: recent advances in inhibitor development, mechanistic insights, and therapeutic prospects. RSC Medicinal Chemistry. 16(12). 5843–5861.
4.
Long, Yu, Fei Xie, Lianqi Liu, et al.. (2025). Novel Quaternary Ammonium Salt‐Linked STING Agonist Antibody‐Drug Conjugate: Synergistic Activation of Tumor Immunity with Mitigated Off‐Target Toxicity. Advanced Science. 12(31). e02270–e02270. 2 indexed citations
6.
Zhang, Chao, et al.. (2025). Discovery of novel hydrazinyl thiazole derivatives as potent anticancer agents by inhibiting eIF4E/eIF4G interactions. European Journal of Medicinal Chemistry. 297. 117911–117911. 1 indexed citations
8.
Liu, Yuanyuan, Fengyang He, Yahan Zhang, et al.. (2024). Imidazolyl Lipids Enhanced LNP Endosomal Escape for Ferroptosis RNAi Treatment of Cancer. Small. 20(40). e2402362–e2402362. 13 indexed citations
9.
Jiang, Kai, Bo Yuan, Meihua Zhao, et al.. (2022). Effect of Autoinducer-2 Quorum Sensing Inhibitor on Interspecies Quorum Sensing. Frontiers in Microbiology. 13. 791802–791802. 29 indexed citations
11.
Hou, Shi, Wei Li, Xiaohong Yang, et al.. (2019). Design, synthesis and biological evaluation of acridone analogues as novel STING receptor agonists. Bioorganic Chemistry. 95. 103556–103556. 27 indexed citations
12.
Xu, Pingxiang, Liyun Wang, Yi Wu, et al.. (2019). Phencynonate S-isomer as a eutomer is a novel central anticholinergic drug for anti-motion sickness. Scientific Reports. 9(1). 2000–2000. 2 indexed citations
13.
Zhang, Qiyan, Ruiyuan Cao, An Liu, et al.. (2017). Design, synthesis and evaluation of 2,2-dimethyl-1,3-dioxolane derivatives as human rhinovirus 3C protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(17). 4061–4065. 11 indexed citations
14.
Li, Feifei, Long Long, Junhai Xiao, et al.. (2017). A novel hydroxyphenyl hydrazone derivate YCL0426 inhibits cancer cell proliferation through sequestering iron. Anti-Cancer Drugs. 28(10). 1131–1140. 4 indexed citations
15.
Hui, Qi, Wei Sun, Junhai Xiao, et al.. (2013). Design, Synthesis and Biological Activities of a Series of Piperazine Pyrimidine as CCR4 Antagonists. Gaodeng xuexiao huaxue xuebao. 34(9). 2131. 1 indexed citations
16.
Chen, Wenjing, Meina Li, Xiaomei Ling, et al.. (2011). Immobilizing CC chemokine receptor 4’s N-terminal extracellular tail on a capillary to study its potential ligands by capillary electrophoresis. Analytical Biochemistry. 423(1). 1–6. 1 indexed citations
17.
Wang, Hongliang, Junhai Xiao, Dapeng Gao, et al.. (2010). Pharmacophore-based design, synthesis, and biological evaluation of novel chloro-pyridazine piperazines as human rhinovirus (HRV-3) inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(3). 1057–1059. 9 indexed citations
18.
Tian, Songhai, Jian Lin, Jun Zhou, et al.. (2010). Beclin 1-independent autophagy induced by a Bcl-XL/Bcl-2 targeting compound, Z18. Autophagy. 6(8). 1032–1041. 63 indexed citations
19.
Nie, Aihua, Junhai Xiao, Lili Wang, et al.. (2007). Drug discovery based on the structure of FKBP12: Design, synthesis and evaluation of L-1,4-thiazane-3-carboxylic acid derivatives as neuroimmunophilin ligands. Science in China Series B Chemistry. 50(3). 405–417. 2 indexed citations
20.
Zhuang, Xiaomei, et al.. (2005). A simplified model to predict P-glycoprotein interacting drugs from 3D molecular interaction field. International Journal of Pharmaceutics. 309(1-2). 109–114. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026